PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE SAGE THERAPEUTICS, INC. 2014 STOCK OPTION AND INCENTIVE PLANPerformance-Based Restricted Stock Unit Award Agreement • May 2nd, 2023 • Sage Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Sage Therapeutics, Inc. (the “Company”) hereby grants an award of the target number of Performance-based Restricted Stock Units (“PSUs”) listed above (an “Award”) to the Grantee named above. Each PSU shall relate to one share of common stock, par value $0.0001 per share (the “Stock”) of the Company and shall be subject to all of the terms and conditions set forth in this Performance-Based Restricted Stock Unit Award Agreement (the “Agreement”) and the Plan. Capitalized terms used in this Agreement and not otherwise defined will have the meaning set forth in the Plan.
